Everything OnCo dates to 1963: 4 entries, 1 approval, 1 company founded, 1 journal founded and 1 technology. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
4 dated entries in OnCo fall in 1963: 1 approval, 1 company founded, 1 journal founded and 1 technology.
Of those, 4 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Acute leukaemia; Hodgkin and non-Hodgkin lymphoma, rhabdomyosarcoma, neuroblastoma, Wilms tumour
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Bloomington, IN
The founded year on journal records.
Wolters Kluwer Medknow